Similarly, TB-500 has undergone extensive safety evaluation including human research trials showing safety at intravenous doses up to 1,260 mg equivalent, with no dose-limiting toxicities or serious adverse events attributable to the peptide in carefully controlled studies
January 15, 2026: FDA Posts Updates to Mounjaros Drug Warning Label, Strengthening Gastrointestinal Warnings On December 19, 2025, and January 7, 2026, the FDA published updates to Mounjaros drug warning label
It is a powerful antioxidant that aids in various bodily functions such as detoxification, immune system support, and cellular repair
Early phase 3 trial results on retatrutide suggest it may lead to more weight loss than semaglutide
Open Access J Sports Med
Separately, a zinc-quercetin complex demonstrates potent hepatoprotection against cadmium toxicity by alleviating oxidative stress and genotoxicity (137, 138)